WST · Categories · Form 4
WST - SEC Form 4 insider transactions
West Pharmaceutical Services Inc. (WST) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for WST
- SVP, Proprietary Segment Campbell Shane Alden covered exercise/tax liability with 219 shares and converted options into 770 shares, increasing direct ownership by 881% to 613 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Pucci Paolo was granted 791 shares, increasing direct ownership by 7% to 11,854 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Michels Douglas A was granted 791 shares, increasing direct ownership by 2% to 46,496 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Lockhart Stephen H was granted 791 shares, increasing direct ownership by 29% to 3,523 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Lai Goldman Myla was granted 791 shares, increasing direct ownership by 4% to 20,435 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Keller Deborah L was granted 791 shares, increasing direct ownership by 7% to 11,560 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Joseph Molly was granted 791 shares, increasing direct ownership by 22% to 4,398 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Haugen Janet Brutschea was granted 791 shares, increasing direct ownership by 50% to 2,373 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Friel Robert F was granted 791 shares, increasing direct ownership by 17% to 5,513 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Feehery William F was granted 791 shares, increasing direct ownership by 2% to 32,519 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Buthman Mark A was granted 791 shares, increasing direct ownership by 2% to 44,309 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Sr. VP & Chief HR Officer Favorite Annette F exercised 2,817 shares at a strike of $83.47 and sold $859,753 worth of shares (2,817 units at $305.20) (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- VP, Chief Accounting Officer Winters Chad exercised 896 shares at a strike of $173.22 and sold $269,399 worth of shares (896 units at $300.67) (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SEC Form 4 filed by Haugen Janet Brutschea4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SEC Form 4 filed by SVP, GC & Corporate Secretary Finch Norman D. Jr.4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SEC Form 4 filed by President, CEO and Board Chair Green Eric Mark4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SEC Form 4 filed by Sr. VP & Chief HR Officer Favorite Annette F4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SEC Form 4 filed by SVP, Proprietary Segment Campbell Shane Alden4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SEC Form 4 filed by SVP & Chief Financial Officer Mcmahon Robert W.4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SEC Form 4 filed by SVP, Strategy & Corporate Dev Poussot Rodolphe Jean4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SEC Form 4 filed by VP, Chief Accounting Officer Winters Chad4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SVP, Strategy & Corporate Dev Poussot Rodolphe Jean converted options into 383 shares and covered exercise/tax liability with 130 shares, increasing direct ownership by 83% to 561 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- VP & Treasurer Witherspoon Charles converted options into 60 shares and covered exercise/tax liability with 22 shares, increasing direct ownership by 3% to 1,408 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- VP, Chief Accounting Officer Winters Chad converted options into 89 shares and covered exercise/tax liability with 30 shares, increasing direct ownership by 4% to 1,523 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SVP, Strategy & Corporate Dev Poussot Rodolphe Jean converted options into 82 shares and covered exercise/tax liability with 28 shares, increasing direct ownership by 22% to 307 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- VP & Treasurer Witherspoon Charles covered exercise/tax liability with 42 shares and was granted 116 shares, increasing direct ownership by 6% to 1,370 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- VP, Chief Accounting Officer Winters Chad was granted 150 shares and covered exercise/tax liability with 51 shares, increasing direct ownership by 7% to 1,462 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- President, CEO and Board Chair Green Eric Mark was granted 4,419 shares, covered exercise/tax liability with 1,879 shares and converted options into 1,319 shares, increasing direct ownership by 3% to 175,161 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Sr. VP & Chief HR Officer Favorite Annette F covered exercise/tax liability with 186 shares, converted options into 135 shares and was granted 442 shares, increasing direct ownership by 2% to 17,374 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SVP & Chief Financial Officer Mcmahon Robert W. converted options into 4,231 shares and covered exercise/tax liability with 1,250 shares (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SEC Form 4 filed by Director Haugen Janet Brutschea4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SEC Form 4 filed by SVP, GC & Corporate Secretary Finch Norman D. Jr.4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SEC Form 4 filed by Director Haugen Janet Brutschea4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SEC Form 4 filed by SVP & Chief Financial Officer Mcmahon Robert W.4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SEC Form 4 filed by Director Haugen Janet Brutschea4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SEC Form 4 filed by SVP, Proprietary Segment Campbell Shane Alden4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Michels Douglas A was granted 1,071 shares, increasing direct ownership by 2% to 45,171 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Pucci Paolo was granted 1,071 shares, increasing direct ownership by 11% to 10,947 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Haugen Janet Brutschea was granted 1,071 shares, increasing direct ownership by 433% to 1,318 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Friel Robert F was granted 1,071 shares, increasing direct ownership by 30% to 4,682 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Lai Goldman Myla was granted 1,071 shares, increasing direct ownership by 6% to 19,424 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Joseph Molly was granted 1,071 shares, increasing direct ownership by 59% to 2,884 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Hofmann Thomas W was granted 1,071 shares, increasing direct ownership by 2% to 44,637 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Keller Deborah L was granted 1,071 shares, increasing direct ownership by 11% to 10,657 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Feehery William F was granted 1,071 shares, increasing direct ownership by 4% to 31,363 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Lockhart Stephen H was granted 1,071 shares, increasing direct ownership by 65% to 2,708 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Buthman Mark A was granted 1,071 shares, increasing direct ownership by 3% to 42,861 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SEC Form 4 filed by Director Haugen Janet Brutschea4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Sr VP, Chief Financial Officer Birkett Bernard covered exercise/tax liability with 273 shares and exercised 904 shares at a strike of $211.00, increasing direct ownership by 9% to 7,520 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Chief Commercial Officer Reiss-Clark Cindy covered exercise/tax liability with 83 shares and exercised 246 shares at a strike of $211.00, increasing direct ownership by 3% to 5,047 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SVP, GC & Corporate Secretary Mackay Kimberly Banks exercised 246 shares at a strike of $211.00 and covered exercise/tax liability with 93 shares, increasing direct ownership by 11% to 1,512 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Sr. VP & Chief HR Officer Favorite Annette F exercised 246 shares at a strike of $211.00 and covered exercise/tax liability with 84 shares, increasing direct ownership by 2% to 6,739 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- VP, Chief Accounting Officer Winters Chad exercised 82 shares at a strike of $211.00 and covered exercise/tax liability with 28 shares, increasing direct ownership by 4% to 1,363 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- VP & Treasurer Witherspoon Charles exercised 66 shares at a strike of $211.00 and covered exercise/tax liability with 23 shares, increasing direct ownership by 3% to 1,295 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- President, CEO and Board Chair Green Eric Mark exercised 2,461 shares at a strike of $211.00 and covered exercise/tax liability with 700 shares, increasing direct ownership by 1% to 169,669 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Amendment: Director Haugen Janet Brutschea was granted 247 shares (SEC Form 4)4/A - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- Director Haugen Janet Brutschea was granted 424 shares (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- VP & Treasurer Witherspoon Charles exercised 478 shares at a strike of $173.22 and sold $218,211 worth of shares (703 units at $310.40), decreasing direct ownership by 15% to 1,253 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- SVP, Chief Technology Officer Abraham Silji covered exercise/tax liability with 180 shares and converted options into 458 shares, increasing direct ownership by 10% to 3,138 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)
- VP & Treasurer Witherspoon Charles exercised 529 shares at a strike of $102.51 and sold $308,700 worth of shares (1,029 units at $300.00), decreasing direct ownership by 25% to 1,478 units (SEC Form 4)4 - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Issuer)